BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26890465)

  • 1. Nationwide and population-based prescription patterns in bipolar disorder.
    Kessing LV; Vradi E; Andersen PK
    Bipolar Disord; 2016 Mar; 18(2):174-82. PubMed ID: 26890465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in prescription patterns to patients with bipolar syndromes. Increased use of lamotrigine and decreased use of lithium].
    Karanti A; Kardell M; Lundberg U; Landén M
    Lakartidningen; 2014 Dec; 111(51-52):2284-6. PubMed ID: 25514669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in mood stabilizer prescription patterns in bipolar disorder.
    Karanti A; Kardell M; Lundberg U; Landén M
    J Affect Disord; 2016 May; 195():50-6. PubMed ID: 26859073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea.
    Yoon W; Shon SH; Hong Y; Joo YH; Lee JS
    J Korean Med Sci; 2018 Nov; 33(46):e290. PubMed ID: 30416410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
    Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009.
    Greil W; Häberle A; Haueis P; Grohmann R; Russmann S
    J Affect Disord; 2012 Feb; 136(3):534-42. PubMed ID: 22134044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.
    Malhi GS; Adams D; Cahill CM; Dodd S; Berk M
    Drugs; 2009 Oct; 69(15):2063-101. PubMed ID: 19791827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
    Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
    Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP.
    Haeberle A; Greil W; Russmann S; Grohmann R
    BMC Psychiatry; 2012 Sep; 12():153. PubMed ID: 22998655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
    Wolfsperger M; Greil W; Rössler W; Grohmann R
    J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial changes in prescription recommendations for bipolar disorder in Canada: 2002-2010.
    Bulloch AG; Bresee LC; Beck CA; Patten SB
    Can J Psychiatry; 2012 Apr; 57(4):263-8. PubMed ID: 22480592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
    Bramness JG; Grøholt B; Engeland A; Furu K
    J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lithium protect against dementia?
    Kessing LV; Forman JL; Andersen PK
    Bipolar Disord; 2010 Feb; 12(1):87-94. PubMed ID: 20148870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
    Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
    Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of road injuries in patients with bipolar disorder and associations with drug treatments: A population-based matched cohort study.
    Chen VC; Yang YH; Lee CP; Wong J; Ponton L; Lee Y; McIntyre RS; Huang KY; Wu SI
    J Affect Disord; 2018 Jan; 226():124-131. PubMed ID: 28972929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar disorder.
    Mitchell PB
    Aust Fam Physician; 2013 Sep; 42(9):616-9. PubMed ID: 24024220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
    Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
    JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study.
    Bjørklund L; Horsdal HT; Mors O; Østergaard SD; Gasse C
    Acta Neuropsychiatr; 2016 Apr; 28(2):75-84. PubMed ID: 26357986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.